These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 36430817)

  • 1. Targeting the Complement-Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy.
    Trivedi VS; Magnusen AF; Rani R; Marsili L; Slavotinek AM; Prows DR; Hopkin RJ; McKay MA; Pandey MK
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C5a Activates a Pro-Inflammatory Gene Expression Profile in Human Gaucher iPSC-Derived Macrophages.
    Serfecz JC; Saadin A; Santiago CP; Zhang Y; Bentzen SM; Vogel SN; Feldman RA
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease.
    Pandey MK; Burrow TA; Rani R; Martin LJ; Witte D; Setchell KD; Mckay MA; Magnusen AF; Zhang W; Liou B; Köhl J; Grabowski GA
    Nature; 2017 Mar; 543(7643):108-112. PubMed ID: 28225753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C5aR1 signaling triggers lung immunopathology in COVID-19 through neutrophil extracellular traps.
    Silva BM; Gomes GF; Veras FP; Cambier S; Silva GV; Quadros AU; Caetité DB; Nascimento DC; Silva CM; Silva JC; Damasceno S; Schneider AH; Beretta F; Batah SS; Castro IM; Paiva IM; Rodrigues T; Salina A; Martins R; Cebinelli GC; Bibo NL; Jorge DM; Nakaya HI; Zamboni DS; Leiria LO; Fabro AT; Alves-Filho JC; Arruda E; Louzada-Junior P; Oliveira RD; Cunha LD; Van Mol P; Vanderbeke L; Feys S; Wauters E; Brandolini L; Aramini A; Cunha FQ; Köhl J; Allegretti M; Lambrechts D; Wauters J; Proost P; Cunha TM
    J Clin Invest; 2023 Jun; 133(12):. PubMed ID: 37104043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An unexpected player in Gaucher disease: The multiple roles of complement in disease development.
    Pandey MK; Grabowski GA; Köhl J
    Semin Immunol; 2018 Jun; 37():30-42. PubMed ID: 29478824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis.
    Carvelli J; Demaria O; Vély F; Batista L; Chouaki Benmansour N; Fares J; Carpentier S; Thibult ML; Morel A; Remark R; André P; Represa A; Piperoglou C; ; ; Cordier PY; Le Dault E; Guervilly C; Simeone P; Gainnier M; Morel Y; Ebbo M; Schleinitz N; Vivier E
    Nature; 2020 Dec; 588(7836):146-150. PubMed ID: 32726800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Complement C5a-C5aR1 GPCR Axis in COVID-19 Therapeutics.
    Woodruff TM; Shukla AK
    Trends Immunol; 2020 Nov; 41(11):965-967. PubMed ID: 33023856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ras-Related Protein Rab5a Regulates Complement C5a Receptor Trafficking, Chemotaxis, and Chemokine Secretion in Human Macrophages.
    Wu KC; Condon ND; Hill TA; Reid RC; Fairlie DP; Lim J
    J Innate Immun; 2023; 15(1):468-484. PubMed ID: 36882040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C5a drives the inflammatory response with bacterial dose effect by binding to C5aR1 in zebrafish infected with Aeromonas hydrophila.
    Liu X; Wang W; Tan S; Liu H; Li Z; Wang N; Ma J; Han S; Wu Z; Shi K; Sha Z
    Fish Shellfish Immunol; 2023 Aug; 139():108873. PubMed ID: 37271327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Involvement of the complement cascade in severe forms of COVID-19].
    Chouaki Benmansour N; Carvelli J; Vivier É
    Med Sci (Paris); 2021 Apr; 37(4):333-341. PubMed ID: 33835019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement cascade in severe forms of COVID-19: Recent advances in therapy.
    Chouaki Benmansour N; Carvelli J; Vivier E
    Eur J Immunol; 2021 Jul; 51(7):1652-1659. PubMed ID: 33738806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19: A collision of complement, coagulation and inflammatory pathways.
    Chauhan AJ; Wiffen LJ; Brown TP
    J Thromb Haemost; 2020 Sep; 18(9):2110-2117. PubMed ID: 32608159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement C5a Induces Pro-inflammatory Microvesicle Shedding in Severely Injured Patients.
    Karasu E; Demmelmaier J; Kellermann S; Holzmann K; Köhl J; Schmidt CQ; Kalbitz M; Gebhard F; Huber-Lang MS; Halbgebauer R
    Front Immunol; 2020; 11():1789. PubMed ID: 32983087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling and analysis of the complement system signalling pathways: roles of C3, C5a and pro-inflammatory cytokines in SARS-CoV-2 infection.
    Murad D; Zafar Paracha R; Saeed MT; Ahmad J; Mushtaq A; Humayun M
    PeerJ; 2023; 11():e15794. PubMed ID: 37744234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV.
    Jiang Y; Zhao G; Song N; Li P; Chen Y; Guo Y; Li J; Du L; Jiang S; Guo R; Sun S; Zhou Y
    Emerg Microbes Infect; 2018 Apr; 7(1):77. PubMed ID: 29691378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C5a/C5aR1 Pathway Is Critical for the Pathogenesis of Psoriasis.
    Zheng QY; Liang SJ; Xu F; Li GQ; Luo N; Wu S; Li Y; Tang M; Zhong Y; Chen J; Yang D; Sun DD; Zhang KQ; Xu GL
    Front Immunol; 2019; 10():1866. PubMed ID: 31447855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-existing humoral immune comebacks control the development of the severe form of coronavirus disease 2019 in Gaucher patients.
    Pandey MK
    Clin Transl Discov; 2022 Jun; 2(2):e96. PubMed ID: 35942236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The critical role of C5a as an initiator of neutrophil-mediated autoimmune inflammation of the joint and skin.
    Sadik CD; Miyabe Y; Sezin T; Luster AD
    Semin Immunol; 2018 Jun; 37():21-29. PubMed ID: 29602515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19.
    Aiello S; Gastoldi S; Galbusera M; Ruggenenti P; Portalupi V; Rota S; Rubis N; Liguori L; Conti S; Tironi M; Gamba S; Santarsiero D; Benigni A; Remuzzi G; Noris M
    Blood Adv; 2022 Jan; 6(3):866-881. PubMed ID: 34852172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Complement System Component C5a Produces Thermal Hyperalgesia via Macrophage-to-Nociceptor Signaling That Requires NGF and TRPV1.
    Shutov LP; Warwick CA; Shi X; Gnanasekaran A; Shepherd AJ; Mohapatra DP; Woodruff TM; Clark JD; Usachev YM
    J Neurosci; 2016 May; 36(18):5055-70. PubMed ID: 27147658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.